AvePoint (FRA:3WZ0) Research & Development: €46.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3WZ0 AvePoint Inc FRA:3WZ0
79 GF Score
Price €11.00
GF Value €11.43
! 1 Warning Sign
View Full Analysis

What is AvePoint Research & Development?

AvePoint FRA:3WZ0 +1.85% 79 Research & Development is €46.1 Mil as of Mar. 2026. GuruFocus rates FRA:3WZ0 with a GF Score™ of 79/100 and a GF Value™ of €11.43. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. AvePoint's Research & Development for the three months ended in Mar. 2026 was €11.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €46.1 Mil.

AvePoint  (FRA:3WZ0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AvePoint Research & Development Related Terms

AvePoint Research & Development Historical Data

* Premium members only.

The historical data trend for AvePoint's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AvePoint Research & Development Chart

AvePoint Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 28.45 29.60 33.32 46.51 44.91

AvePoint Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.74 11.24 11.87 11.10 11.90
FRA:3WZ0
79GF Score
AvePoint Inc FRA:3WZ0
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AvePoint Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €46.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €46.1 Mil mean?
AvePoint (FRA:3WZ0) has a Research & Development of €46.1 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on AvePoint and its competitors.
Is AvePoint's Research & Development too high?
AvePoint's current Research & Development is €46.1 Mil. Overall, AvePoint has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does AvePoint's Research & Development compare to NN and CALX?
AvePoint's Research & Development of €46.1 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on AvePoint and its competitors. AvePoint's current Research & Development is €46.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AvePoint stock overvalued right now?
AvePoint (FRA:3WZ0) has a current Research & Development of €46.1 Mil. The stock's GF Value™ is €11.43, compared to a current price of €11.00 — trading 3.8% below its estimated fair value. The current Research & Development is €46.1 Mil. AvePoint's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For AvePoint (FRA:3WZ0), the current Research & Development is €46.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AvePoint (FRA:3WZ0) Overvalued in 2026?

Based on GuruFocus' analysis, AvePoint stock appears to be undervalued. The current stock price of €11.00 is trading 3.8% below its estimated GF Value™ of €11.43.

Key valuation signals for FRA:3WZ0:

  • Research & Development: €46.1 Mil
  • GF Value™: €11.43 vs. price of €11.00 (3.8% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the FRA:3WZ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AvePoint Business Description

Other Exchanges AVPT:USAAVP:Singapore
Address 525 Washington Boulevard, Suite 1400, Jersey City, NJ, USA, 07310
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
79GF Score

Get the complete analysis for FRA:3WZ0

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.00
Price
€11.43
GF Value